the Effect of Carbetocin in Decreasing Intraoperative Blood Loss in Abdominal Myomectomy

• Status: Completed
• Trial end date: 2020-02-20
• Target enrollment: 0
• Participant gender: Female

Summary

To investigate the effectiveness of carbetocin on reducing intraoperative blood loss during abdominal myomectomy

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Cairo University
• Treatments: Carbetocin; Oxytocin

Criteria

Inclusion Criteria:

• • Patients presenting for abdominal myomectomy with documented uterine fibroids on pelvic imaging

• Age ≥ 25 years and ≤ 50 years

• Pre-operative hemoglobin >10 g/dl

• Ability to understand and the willingness to sign a written informed consent.

• Admissible medical/surgical history

• Five or less symptomatic uterine myomas

• symptomatic stage 3 to 6 fibroids, according to FIGO staging

Exclusion Criteria:

• • Post-menopausal women

• Patients with known bleeding/clotting disorders

• Patients with a history of gynecologic malignancy

• Hypertension.

• Cardiac and Pulmonary diseases.

• History of allergic reactions attributed to carbetocin